TrovaGene Inc (NASDAQ:TROV) And Novogene Enter Agreement Over Nextcollect

Novogene has revealed that it is entering into a deal with TrovaGene Inc (NASDAQ:TROV), a firm focusing on precision medicine biotechnology with a view to acquiring NextCollect, a proprietary device for nucleic acid preservation and urine collection. Besides selling Nextcollect to Novogene, Trovagene will also sell reagents and methods of extracting from urine cell-free DNA. […]

TrovaGene Inc (NASDAQ:TROV) Collaborates With Global Biopharmaceutical Company Ahead Of Its Cancer Clinical Trials

TrovaGene Inc (NASDAQ:TROV), which happens to be a top end precision medicine biotechnology provider has proceeded to make the much awaited announcement. Through one of its top officials, it revealed that it was going to collaborate with a worldwide, premier biopharmaceutical company, an agreement that would see the two engage in the provision of Trovera┬« […]